Allergic Asthma Clinical Trials

6 recruiting

Frequently Asked Questions

Common questions about Allergic Asthma clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 1Phase 2

Safety and Immunogenicity of Cat-allergen Intralymphatic Immunotherapy in Patients With Cat Allergy With and Without Asthma

Allergic AsthmaAllergic Rhinitis
University of Zurich36 enrolled1 locationNCT06960382
Recruiting

ROLL'YN-OMA: an Observational Study in Patients Treated by Omlyclo®, an Omalizumab Biosimilar

Chronic Spontaneous Urticaria (CSU)Allergic Asthma
Celltrion HealthCare France225 enrolled1 locationNCT07425639
Recruiting
Phase 2

Evaluate the Efficacy and Safety of FB825 in Adult With Allergic Asthma

Allergic Asthma
Oneness Biotech Co., Ltd.100 enrolled13 locationsNCT05008965
Recruiting
Phase 2

Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients

Allergic Asthma
Longbio Pharma200 enrolled1 locationNCT07342803
Recruiting
Not Applicable

Creating A Risk Assessment Tool for Thunderstorm Asthma: the CARISTA Study

Allergic AsthmaAsthma AcuteThunderstorm Asthma+3 more
University of Melbourne530 enrolled1 locationNCT07055542
Recruiting
Not Applicable

Development of a Novel Non-invasive Inflammometry Following Allergen Challenge in Patients With Mild Allergic Asthma

Mild Allergic Asthma
Fraunhofer-Institute of Toxicology and Experimental Medicine15 enrolled1 locationNCT06317909
Recruiting
Phase 3

A Histamine Pharmacodynamic Biomarker to Guide Treatment in Pediatric Asthma (HAS3)

Allergic Asthma
Bridgette Jones300 enrolled1 locationNCT04699604
Recruiting

A Clinical Study of Omalizumab in the Treatment of Allergic Asthma(ESSENCE)

Moderate to Severe Allergic Asthma
The First Affiliated Hospital with Nanjing Medical University300 enrolled1 locationNCT06348407